Check out our article in this month's Contract Pharma magazine, which discusses how next-gen biotherapeutics and direct-to-patient (DTP) trials are disrupting traditional clinical trial supply models, including the need for quick-turn/small-batch labels. Click here for more information about our clinical trial capabilities.
